CD44 and prostate cancer: MiR-548c-3p overexpression has been mainly detected in a CD133+α2β1Hi CD44+ prostate cancer subpopulation, and exhibits stem cell properties [212,213], while it is associated with induction of stem cell-related genes, self-renewal, and radioresistance [75].